Topic: How To Invest

Q: Please, may I have your comments on Cooper Companies (NYSE:COO)? Thank you.

Article Excerpt

A: The Cooper Companies Inc., $399.89, symbol COO on New York (Shares outstanding: 49.3 million; Market cap: $19.5 billion; www.coopercos.com), is a California-based healthcare business with two operating segments. The first, Cooper Vision (75% of revenues), manufactures and markets soft contact lenses for the vision-correction market worldwide. It specializes in lenses for common eye conditions like astigmatism, presbyopia, and ocular dryness. The second, Cooper Surgical (25%), develops and markets the medical devices, diagnostic products, and surgical instruments and accessories used by gynecologists and obstetricians. In December 2021, Cooper completed the acquisition of Generate Life Sciences for $1.6 billion. Generate Life Sciences was created by GI Partners in 2018 as the combination of California Cryobank Life Sciences, an industry-leading donor sperm and egg bank, and Cord Blood Registry, a leading provider of newborn stem cell services. Generate aims to serve families from preconception to post-birth. Headquartered in Los Angeles, Generate also operates facilities in Tucson, New York, Boston, Palo Alto, Texas, and Rockville, Maryland…